Wallin-Håkanson N, Wallin-Håkanson B
Referral Animal Hospital Strömsholm, 730 40 Kolbäck, Sweden.
Vet Ophthalmol. 2001 Mar;4(1):3-6. doi: 10.1046/j.1463-5224.2001.00114.x.
Twenty normal Golden Retrievers being screeened for eye, hip and elbow diseases were given tropicamide topically and medetomidine systemically. Medetomidine effects were later reversed with systemic atipamezole. Pupil size and intraocular pressure changes were determined. Pupil size increased significantly following tropicamide administration and continued to increase slightly but significantly after medetomidine injection. It was unclear whether the slight increase in pupil size following medetomidine administration was due to continued effect of tropicamide or due to the medetomidine itself. Atipamezole did not influence pupil size. Intraocular pressure (IOP) was not affected by these drugs. Ophthalmic screening examination for inherited disease following tropicamide administration is equally feasible prior to sedation with medetomidine and after reversal with atipamezole, but not during the period of sedation.
对20只正在接受眼部、髋部和肘部疾病筛查的正常金毛寻回犬进行了局部托吡卡胺和全身美托咪定给药。随后通过全身注射阿替美唑来逆转美托咪定的作用。测定了瞳孔大小和眼压变化。给予托吡卡胺后瞳孔大小显著增加,注射美托咪定后瞳孔大小继续略有但显著增加。尚不清楚美托咪定给药后瞳孔大小的轻微增加是由于托吡卡胺的持续作用还是美托咪定本身的作用。阿替美唑不影响瞳孔大小。这些药物对眼压(IOP)没有影响。在使用美托咪定镇静前和用阿替美唑逆转后进行托吡卡胺给药后的遗传性疾病眼科筛查检查同样可行,但在镇静期间不行。